ConductScience.org, home
IGF2BP3: insulin like growth factor 2 mRNA binding protein 3
API referenceFor AI assistants

Gene · 10643

Papers3,038

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 3,038

Download this page as JSON
TitleJournalYearPMIDFound bySource
Integrative In Silico Multi-Omics Profiling of circRNA-Mediated ceRNA Networks Reveals Prognostic Biomarkers and Repurposed Therapeutic Candidates in Gastric Cancer.Int J Mol Sci202641828401PubTator, text miningPubMed
Single-cell RNA sequencing reveals the neuronal transcriptional differentiation program associated with ferroptosis-related heterogeneity in human hepatoblastoma.Comput Biol Chem202641825257PubTator, text miningPubMed
Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer.J Exp Clin Cancer Res202641814321PubTator, text miningPubMed
Development and external validation of a mitophagy-related diagnostic model for biliary atresia based on cellular infiltration patterns.Transl Pediatr202641810177PubTator, text miningPubMed
Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients.Front Oncol202641809822PubTator, text miningPubMed
Roles of RNA-binding proteins in macrophage function regulation and immunotherapy.Front Cell Dev Biol202641808933PubTator, text miningPubMed
ARPC1B promotes gastric cancer tumorigenesis via IGF2BP3-mediated stabilization of HK2 mRNA and glycolytic reprogramming.Eur J Med Res202641803983PubTator, text miningPubMed
EWSR1 as a regulatory target in hepatic stellate cell apoptosis and liver fibrosis therapy.Biochem Biophys Rep202641799701PubTator, text miningPubMed
Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation.Oncol Res202641799520PubTator, text miningPubMed
LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity.Open Med (Wars)202641798908PubTator, text miningPubMed
IGF2BP3-GP130-STAT3-WTAP loop promotes the malignant progression in glioblastoma.Cell Signal202641796649PubTator, text miningPubMed
RBM15B promotes hepatocellular carcinoma progression via IGF2BP1-mediated ITSN2 mRNA stabilization.J Cancer Res Clin Oncol202641795047PubTator, text miningPubMed
CAPZA1 Suppressed the Progression of Esophageal Squamous Cell Carcinoma by Binding to hnRNP K and PTPB1 to Influence Its mRNA Stability.Cancer Med202641787560PubTator, text miningPubMed
LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.BMC Cancer202641787385PubTator, text miningPubMed
IGF2BP3 promotes the muscle invasion of bladder cancer via PPARγ dysregulation.Discov Oncol202641787033PubTator, text miningPubMed
CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction.Front Immunol202641782876PubTator, text miningPubMed
Circ_0003323 binds METTL1 to mediate KLK6 m7G methylation modification and promote the progression of colorectal cancer.iScience202641782829PubTator, text miningPubMed
Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy.Int J Nanomedicine202641773242PubTator, text miningPubMed
The Role of DNA Methylation in Osteosarcoma Pathogenesis and Therapy.Onco Targets Ther202641768085PubTator, text miningPubMed
The emerging role of m6A methylation in prostate-related diseases: mechanisms and clinical implications.Front Immunol202641766860PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10643/papers?page=5

API referenceFor AI assistants